Recently, several studies proposed a physiological role for the cellular prion protein (PrP c ) in defense against oxidative stress. Since the pathogenesis of prion disease necessarily involves a disturbance of PrP c homeostasis, we hypothesized that such diseases would be associated with concomitant disturbances in oxidative balance. In support of such a notion, in this study we show increased oxidative damage to nucleic acids in affected brains of patients with Creutzfeldt-Jakob disease. These data suggest that damage by free radicals is a likely cause for neurodegeneration in human prion disease, and antioxidants are a potential therapy for these disorders. Further, our data support the hypothesis that loss of the anti-oxidant function of PrP c plays a key role in the pathogenesis of these disorders.
INTRODUCTION
Transmissible spongiform encephalopathies or prion diseases are infectious, inherited or sporadic neurodegenerative disorders (for a review see (Prusiner, 1998) ). Human prion diseases include Creutzfeldt-Jakob disease (CJD), Gerstmann-Sträussler-Scheinker disease, kuru and fatal familial insomnia (FFI). The infectious agent (prion) in prion disease, different from both viroids and viruses (Prusiner, 1982) , is considered to be formed by an abnormal isoform (PrP Sc ) of the host-encoded prion protein (PrP c ). However, the biological basis of disease manifestation and cell loss remains unknown and likely involves either loss of function for PrP c (Collinge et al., 1994) or neurotoxicity of accumulated PrP Sc (Forloni et al., 1993) . PrP c is a copper binding (Brown et al., 1997a) , membrane-attached GPI-anchored glycoprotein characterized by a high degree of amino acid sequence conservation within mammals (Prusiner, 1998).
There is increasing evidence obtained by morphological and biochemical examination of diseased brains, that oxidative stress, resulting from damage by free radicals to lipids, carbohydrates, proteins, and nucleic acids, is involved in neurodegenerative disorders as Alzheimer's disease (Nunomura et al., 1999a (Nunomura et al., , 2000 Smith et al., 1997 ), Down's syndrome (Nunomura et al., 2000) , amyotrophic lateral sclerosis (Cookson and Shaw, 1999), Parkinson's disease (Zhang et al., 2000) , and Huntington's disease (Browne et al., 1999) . These investigations have led to a better understanding of the pathogenesis of neurodegeneration and raised hopes for the development of novel (antioxidant) therapeutic approaches (Rottkamp et al., 2000) .
Recently, others and we have indicated a key role for PrP c in the cellular response and resistance to oxidative stress. Neurons and astrocytes from mice deficient in PrP c were shown to be more sensitive to oxidative stress (Brown et al., 1997c (Brown et al., , 1998 White et al., 1999) and PrP c has an activity like that of superoxide dismutase (Brown et al., 1999; Wong et al., 2000) . Further, in mice devoid of prion protein, higher levels of oxidative damage to proteins and lipids and induction
